Supplementary Figures 1 - 2 from S100B Promotes Glioma Growth through Chemoattraction of Myeloid-Derived Macrophages
Huaqing Wang(Population Health Research Institute), Behnam Badie(City Of Hope National Medical Center), Hui Ren(Tongji University), Xuebo Chen, Charles Warden(City Of Hope National Medical Center), Sam Badie(City Of Hope National Medical Center), Mao Ouyang(Central South University), Shihua Wu, Leying Zhang(City Of Hope National Medical Center), Ian Y. Zhang(Beijing Tongren Hospital), Anna Da Fonseca(Universidade Federal do Rio de Janeiro), Sam Sadeghi(City Of Hope National Medical Center)
Cited by 0
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
|Frontiers in Immunology|2017|216
Carbon Nanotubes Enhance CpG Uptake and Potentiate Antiglioma Immunity
|Clinical Cancer Research|2010|180